Cinnamomum cassia Blume (CC) is one of the world's oldest natural spices, and is commonly used in traditional oriental medicine. We investigated the protective effect of ethanol extract from Cinnamomum cassia Blume (CCE) on the activation of hepatic stellate cells (HSCs). In addition, we examined the effects of CC powder in Sprague-Dawley rats with acute liver injury induced by dimethylnitrosamine (DMN). In vitro, HSC-T6 cells exhibit an activated phenotype, as reflected in their fibroblast-like morphology. CCE significantly reduced the expression of alpha-smooth muscle actin (-SMA), connective tissue growth factor (CTGF), transforming growth factor beta (TGF-1), and tissue inhibitor of metalloproteinase-1 (TIMP-1). In vivo, the results were significantly protected by CC powder in the serum total protein, albumin, total-bilirubin, directbilirubin, glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), and alkaline phosphatase (ALP). We suggest that CC inhibits fibrogenesis, followed by HSC-T6 cell activation and increased restoration of liver function, ultimately resulting in acute liver injury.
Key words: hepatic stellate cell (HSC)-T6; alphasmooth muscle actin (-SMA); dimethylnitrosamine; Cinnamomum cassia Blume Hepatic fibrosis is a wound-healing response to chronic liver injury that can lead to cirrhosis and liver failure if repetitive liver damage occurs. Currently, fibrosis is known to be part of a dynamic process of continuous extracellular matrix (ECM) remodeling in the setting of chronic liver injury, which leads to an excessive accumulation of several extracellular proteins, proteoglycans, and carbohydrates. 1, 2) The damaged hepatocytes, their membrane components, metabolites of toxic agents, and infiltrating inflammatory cells are activators of Kuffer cells.
3) Activated Kuffer cells release a number of soluble agents, including cytokines, reactive oxygen species, and other factors. These factors act as activators of hepatic stellate cells (HSCs). 4) HSCs have been established as the primary source of ECM in liver injury. 5) In the normal liver, HSCs comprise approximately 1.4% of total liver volume and are present at a ratio of about 3.6 to 6 cells per 100 hepatocytes. 6) After acute liver injury and in chronic liver disease, quiescent HSCs become activated and trans-differentiate into myofibroblast-like cells characterized by several key phenotypic changes, such as enhanced cell migration and adhesion, expression of alpha smooth muscle actin (-SMA), increased proliferation, accumulation of ECM, including a1 (I) collagen, and loss of stored vitamin A droplets. 1, 7) Dimethylnitrosamine (DMN) is a potent hepatotoxin, carcinogen, and mutagen. It is well known that repeated injections of low-dose DMN cause liver fibrosis or cirrhosis. 8) A low dose of DMN initially causes diffuse hemorrhagic necrosis, leading to mononuclear cell infiltration of the liver 9, 10) and subacute and chronic liver injury, with varying degrees of fibrosis and nodular regeneration. 11, 12) A high dose of DMN administered in one injection to an experimental animal resulted in submassive necrosis that resembled human fulminant hepatitis. 13) Hence this compound has been widely used as a model agent to study the mechanisms of liver injury.
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14) It is reported to reduce blood pressure in experimental rats, 15) and it has significant antiallergic, antiulcerogenic, antipyretic, and anaesthetic effects. 16) It has been studied recently in diabetics for its antidiabetic effects. 17, 18) It also has various effects in the digestive system, but the effects of CC on liver damage have not been studied extensively. In this present study, the effects of an ethanol extract of Cinnamomum cassia Blume (CCE) on the index of liver fibrosis were investigated in activated HSC-T6 cells. In addition, we examined the effects of CC powder in Sprague-Dawley rats with acute liver injury induced by DMN.
Materials and Methods
HPLC analysis of standard material for sample testing. Extraction of cinnamaldehyde from CC hot water extract was carried out according a modification of the method of He et al. 19) About 2.0 g of a mixed, fine-powdered sample of CC was weighed, put in a 500-ml round plate bottom flask, dissolved with 50 ml of methanol (HPLC grade, 4 liters, Millinckrodt Baker, Phillipsburg, NJ) by refluxing for 2 h at 75 C twice, and then centrifuged for 15 min at 3,000 rpm at room temperature (RT). The upper solution was filled to 200 ml with methanol. The standard material was accurately weighed to 10.0 mg and dissolved in 10 ml of methanol. The dissolved standard solution was diluted to 0.25, 0.5, and 1.0 mg/ml. Afterwards, a standard HPLC chromatogram was obtained.
HPLC analysis was carried out with a Waters 2695 Alliance System with a 2996 PDAD detector and a Waters Empower System (Ver. 5.00, Waters, Milford, MA). The test sample was analyzed by reverse-phased HPLC on a C18 column (XTerraÔ, 5 mm ODS, 150 mm Â 3:9 mm (I.D), Waters) in an isocratic condition of acetonitrile/water/acetic acid glacial (30:69:1 v/v) at 0.8 ml/min with detection at 280 nm and injections in portions of 10 ul; the total run time was 30 min.
Effects of CCE on HSC-T6 cells. Preparation of CCE. One-hundred g of CC was extracted with 80% ethanol in RT for 2 weeks and filtered with Whatman filter paper no. 3. The ethanol extract was concentrated with a rotary vacuum evaporator, lyophilized, and stored at À20 C until use. After ethanol treatment, 10% of CC was recovered.
Reagents. Phorbol-12-myristate-13-acetate (PMA) was purchased from Sigma (St. Louis, MO). Antibodies against tissue inhibitor of metalloproteinase (TIMP)-1, connective tissue growth factor (CTGF), receptor of platelet-derived growth factor (PDGFR)-, and proliferating cell nuclear antigen (PCNA) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The antibody of -SMA was obtained from Neomarker (Fremont, CA), and the antibody of transforming growth factor beta (TGF-) was from Promega (Madison, WI).
Culture of the HSC-T6 cell line. HSC-T6 cells, an immortalized rat myofibroblast line that has a phenotype and biological characteristics similar to those of primary stellate cells, were kindly provided by Dr. S. L. Friedman (Mount Sinai School of Medicine, NY). The cells were cultured in DMEM, and supplemented with 10% fetal bovine serum (FBS), 100 units/ml of penicillin, and 100 mg/ml of streptomycin under a humidified atmosphere of 5% CO 2 at 37 C. Measurement of cell viability. In vitro cell cytotoxicity was determined by colorimetric MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] assay. HSC-T6 cells were plated in triplicate in a 96-well microplate at an initial concentration of 2 Â 10 4 cells per well. Approximately 24 h after cell plating, the cells were cultured with various concentrations of CCE (1-100 mg/ml) for 24 h, after which an MTS solution was added to each the well (CellTiter 96 non-radioactive cell proliferation assay kit, Promega). The plate was incubated under 5% CO 2 at 37 C for 120 min. Absorbance was measured on a Molecular Dynamics Plate Reader at 490 nm.
Western blot analysis for -SMA, CTGF, PCNA, PDGFR-, and TGF-1. HSC-T6 cells (5 Â 10 6 ) were seeded on a P-100 dish (Corning, NY) in DMEM supplemented with 10% FBS. After 24 h, the HSC-T6 cells were exposed to various concentrations of CCE (1-100 mg/ml) in the presence of 100 nM PMA for 24 h. The cells were washed twice with cold phosphate-buffered saline (PBS) and lysed with cell lysis buffer (40 mM Tris-HCl, 10 mM EDTA, 120 mM NaCl, 1% Nonident P-40, 1 mM DTT, 1 mM PMSF, 1 mM NaF, P1 cocktail, 1 mM Na 3 VO 4 ) for 30 min. Insoluble debris were removed by centrifugation at 13,000 rpm for 20 min. The supernatants were collected and stored at À70 C until detection. Protein concentrations were analyzed with a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA). Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electrotransferred onto a PVDF membrane (Millipore, Bedford, MA). The membranes were blocked with 5% non-fat milk for 1 h and incubated with anti-TGF-1 antibody (1:1,000 dilution, Promega), anti--SMA antibody (1:1,000 dilution, Neomarker), anti-PCNA (1:1,000 dilution, Santa Cruz), anti-CTGF (1:1,000 dilution, Santa Cruz), anti-actin (1:1,000 dilution, Santa Cruz), and anti-PDGFR-(1:1,000 dilution, Santa Cruz) overnight at 4 C, and then incubated with a suitable horseradish peroxidase (HRP)-conjugated IgG antibody for 1 h at RT.
Western blot analysis for TIMP-1. HSC-T6 cells (2 Â 10 4 ) were seeded on a 96-well plate (Corning, NY) in DMEM supplemented with 10% FBS. After 24 h in DMEM supplemented with 10% FBS, the medium was replaced with serum-free DMEM with various concentrations of CCE (1, 10, and 20 mg/ml) in the presence of 100 nM PMA. After 24 h, the medium was harvested, briefly centrifuged, and immediately frozen at À70 C. Aliquots from identical numbers of HSC-T6 cells were separated by SDS-PAGE and electrotransferred onto a PVDF membrane (Millipore). The membranes were blocked with 5% non-fat milk for 1 h and incubated with anti-TIMP-1 antibody (1:1,000 dilution, Santa Cruz) overnight at 4 C, and then incubated with horseradish peroxidase (HRP)-conjugated IgG antibody for 1 h at RT, and the antibody specific proteins were visualized by an enhanced chemiluminescene (ECL) procedure using an ECL detection reagent (Amersham Pharmacia, Piscataway, NJ). Each immunoreactive band was quantitated with Scion Image Software.
Effects of CC on DMN-induced acute liver injury in rats. Preparation of animals. Animal care and all experimental procedures were conducted in accordance with the ''Guide for Animal Experiments'' edited by the Korean Academy of Medical Sciences. Six-week-old male Sprague-Dawley rats were purchased from Samtako (Seoul, Korea). The rats were housed at 22 AE 2 C at 50 AE 10% humidity under a 12 h-12 h light-dark cycle. The rats were given autoclaved diets (LabDiet #5001, PMI Nutrition international, St. Louis, MO) and water. Prior to the experiments, the rats were allowed to adapt to the laboratory environment for 1 week. DMN was purchased from Sigma (St. Louis, MO). Silymarin, named Legalon 70 (Bukwang Pharmaceuticals, Seoul, Korea) was purchased from a local drugstore. CC was from Omniherb (Youngcheon, Korea).
Induction of acute liver injury. The 32 rats were divided into four groups of eight rats each. The normal group was treated with intraperitoneal injection of 0.15 M NaCl. The control (À) group was treated with an intraperitoneal injection (0.1 ml/100 g) of DMN (diluted with 0.15 M NaCl) at a dose of 40 mg/kg. The silymarin group was treated with an intraperitoneal injection of DMN at a dose of 40 mg/kg, followed by daily treatment with silymarin (suspended in 1 ml of D.W.) at a dose of 100 mg/kg by oral gavage for 4. The CC group was given an intraperitoneal injection of DMN (diluted with saline) at a dose of 40 mg/kg, followed by daily treatment with CC powder (suspended in 1 ml of D.W.) at a dose of 100 mg/100 g by oral gavage for 4. At the end of the study, all the rats in each group were sacrificed under anesthesia with diethylether. The liver and spleen were removed immediately and weighed.
Biochemical analysis of serum. Blood samples for biochemical analysis were obtained from the left ventricle. Serum total protein (T-protein), albumin, total bilirubin (T-Bili), direct bilirubin (D-Bili), glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), and alkaline phosphatase (ALP) were entrusted to SCL (Seoul Clinical Laboratories, Seoul, Korea).
Measurement of hepatic hydroxyproline assay. The hydroxyproline content was determined by the Jamall method, as previously reported. 20) Liver tissue (0.3 g) was homogenized in 6 N HCl and hydrolyzed at 110 C for 18 h. Twenty-five microliter aliquots were dried at 60 C. The sediment was dissolved in 1.2 ml of 50% isopropanol and incubated with 200 ul of 0.56% chloramine T Solution (Sigma) in acetate citrate buffer pH 6.0. After incubation for 10 min at RT, 1 ml of Ehrlich's reagent was added, and the mixture was incubated at 50 C for 90 min. After cooling, absorbance was measured at 558 nm (BECKMAN, Fullerton, CA, DU530).
Liver histopathology. The liver specimens were fixed in 10% neutral buffered formalin and embedded in paraffin. Four-micrometer liver sections were deparaffinized and processed routinely for hematoxylin-eosin (H-E), Masson trichrome, and Van Gieson staining.
Immunohistochemical study. Endogenous peroxidases of the samples for -SMA were blocked by incubation in 3% hydrogen peroxide in methanol for 30 min. The samples were washed 3 times with trisbuffered saline (TBS, pH 7.4) and blocked for 10 min at RT with 10% normal horse serum (Vector, Burlingame, CA) in TBS. After they were washed 3 times with TBS, the samples were incubated for 18 h at 4 C with the appropriate dilution of primary antibody. We used antibodies against mouse -SMA diluted 1 : 200 (Neomarker, Fremont, CA). The samples were rinsed 3 times with TBS and incubated for 30 min at RT with the appropriate dilution of secondary antibody, biotinylated antimouse IgG diluted 1:200 (Zymed, San Francisco, CA). The slides were rinsed with TBS, incubated for 30 min with vectastain ABC solution (enzyme-labeled complexes, Vector, Burlingame, CA), and washed with TBS, after which the signal was detected using 3,3-diaminobenzidine (DAB; Sigma). Alpha-SMA were counterstained with hematoxylin and eosin respectively, and mounted in Canada balsam. The stained sections were examined using an optical microscope (Olympus, Tokyo, BX51).
Imaging analysis. For morphometric analysis, we assessed the mean value of the area of -SMA positive cells in three ocular fields per specimen as percent area at 40Â magnification using an image-analysis system (NIH image 1.62, Bethesda, MD). Alpha-SMA positive cells were expressed as a percentage of the total area of the specimen.
Statistical analysis. All values were expressed as the mean AE standard error. Raw data were subjected to one-way ANOVA, followed by Dunnett's post-hoc comparisons. A p-value of 0:05 was considered statistically significant.
Results

HPLC analysis of standard material for sample testing
From the results for the standard calibration curve, the amounts (mg) of the two standard materials in CC methanol extracts were calculated from the relationship between the concentration and peak area, which were obtained using known amounts of trans-cinnamic acid MTS assays were performed to measure the survival rate of HSC-T6 cells after 24 h of exposure to CCE. Data are expressed as the mean of percent cell viability as compared to normal after exposure for 24 h. Normal, normal group without CCE treatment; CCE-1, sample group treated with 1 mg/ml of CCE; CCE-10, sample group treated with 10 mg/ml of CCE; CCE-100, sample group treated with 100 mg/ml of CCE. Each bar represents the mean AE standard error for three experiments.
and cinnamaldehyde. The amounts of trans-cinnamic acid and cinnamicaldehyde in the CC methanol extracts were qualified as 4:54 AE 0:20 mg/g of extracts (0:45 AE 0:02%) and 141:90 AE 4:49 mg/g of extracts (14:19 AE 0:45%) respectively (Fig. 1) .
Effects of CCE exposure on HSC-T6 cell viability
The response of HSC-T6 cell lines following exposure to CCE is illustrated in Fig. 2 . One, 10, and 100 mg/ml of CCE treatment did not affect viability under the serum condition (Fig. 2) . The cellular viabilities were estimated to be greater than 90%. Each data point represents the average of a series of three different experiments.
Changes in the expression of -SMA, CTGF, PCNA, PDGFR-, and TGF-1
To determine the effects of CCE on -SMA, CTGF, PDGFR-, TGF-1, and PCNA, Western blotting analysis was applied to detect the protein levels. The protein levels of -SMA and PDGFR-in CCE-treated HSC-T6 decreased gradually with increases in the extract concentration from 1 to 100 mg/ml (Fig. 3) . Compared with the untreated normal group, the production of TGF-1 and CTGF was not affected by treatment with 1 and 10 mg/ml CCE. However, 100 mg/ml of CCE decreased the protein levels of TGF-1 and CTGF by about 31.3% and 81.8% respectively. The protein level of PCNA was not different between the CCE-treated group and the normal group.
Change in the expression of TIMP-1
We examined the effect of CCE on the level of TIMP-1 in HSC-T6 cells induced by PMA. Western blotting was performed to determine the effects of CCE on TIMP-1 protein release in the culture medium. As shown in Fig. 4 , PMA induced the expression of TIMP- Protein levels were measured in the lysates prepared from HSC-T6 cells treated with 1-100 mg/ml the CCE for 24 h. Aliquots of cell lysate were subjected to 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto PVDF membranes, and proteins were detected using primary antibodies and horseradish peroxidase-conjugated secondary antibodies. Each image represents typical results of three independent experiments. Vertical bars indicate mean AE standard error.
Ã p < 0:05, ÃÃ p < 0:01, ÃÃÃ p < 0:001 as compared with the normal group.
1 in the HSC-T6 cells. Compared with the PMA treated group, 1, 10, and 20 mg/ml of CCE reduced the expression of TIMP-1 by about 14.5%, 25.8%, and 64.7% respectively after the 24-h treatment (Fig. 4) .
Biochemical analysis of serum
The effects of CC powder on serum parameters in the acute liver injury model are shown in Fig. 5 . Serum T-protein (p < 0:001), albumin (p < 0:001), T-Bili (p < 0:01), D-Bili (p < 0:001), GOT (p < 0:01), GPT (p < 0:05), and ALP (p < 0:001) significantly recovered in the CC-treated group as against control (À). On the other hand, the silymarin-treated group significantly decreased only in ALP (p < 0:001) (Fig. 5) .
Change in -SMA expression Expression of -SMA, an indicator of activated HSCs, 5, 21) was detected by the immunohistochemistry method. The means of the -SMA positive regions at 100Â magnification were 1:89 AE 0:21%, 1:65 AE 0:22%, and 1:44 AE 0:15% in the control (À), silymarin-, and CC-treated group respectively at 4 after DMN injection. Activation of -SMA was inhibited in the CC-treated group (Fig. 6 ).
Discussion
The HSC-T6 cell line exhibits an activated phenotype and displays a fibroblast-like morphology. The HSC-T6 cell line is constructed by transfection with SV40 sequences into rat HSCs, and its phenotype is activated HSCs. 22, 23) The infiltrating cells trigger activation of HSC-secreted cytokines such as TGF-and PDGF. 24, 25) Typically, liver injury leads to activation of HSCs, and progresses to chronic fibrosis and finally to cirrhosis with chronic liver failure. Hence it is important that medicinal treatment of liver injury should include not only restoration of liver function but also inhibition of liver fibrosis.
Among the many drugs for liver injury, silymarin is the clinically most prescribed drug. It is known to have hepatotherapeutic and anti-fibrotic properties. 26, 27) Hence we used silymarin as the positive control in this experiment.
In hepatic fibrosis, an increase in TGF-has been demonstrated in cirrhosis, 28) experimental hepatic fibrosis, and cultured activated HSCs. 29) TGF-leads to perpetual HSC activation by prompting HSCs to transit into myofibroblasts, stimulating the synthesis of ECM (extracellular matrix) and inhibiting its degradation. 30) TGF induces overexpression of CTGF during hepatic fibrogenesis. CTGF is selectively induced by TGF-in fibroblastic cell types, and it plays a key role in the HSC-T6 cells were treated with CCE (1, 10, and 20 mg/ml) in the presence of PMA (100 nM) for 24 h. Conditioned media were collected and loaded on a 12% SDS-polyacrylamide gel. Western blotting was performed with anti TIMP-1 antibody.
ÃÃ p < 0:01 as compared with the PMA group. overproduction of ECM in activated HSCs. CTGF expression in HSCs is significantly enhanced during the activation process in vitro and in vivo. 31, 32) Our experiment indicated that TGF-1 and CTGF were decreased by CCE treatment. Considering that CCE decreased TGF-1 and CTGF expression at the same concentration, CCE might control CTGF through inhibition of TGF-1. Expression of PDGFR is also one of the key events in HSC activation. PDGFR participates in proliferation and migration response. 5, 33) PDGF is the most potent proliferative stimulus towards stellate cells. 34) Both PDGF 35) and its receptor 36) are upregulated following liver injury. The mitogenic capability of PDGF in stellate cells requires activation-dependent expression of the receptor. 37) Quiescent stellate cells express PDGFR-, while activated stellate cells express both PDGFR-and PDGFR-. 36) Myofibroblasts that synthesize and secrete collagen I during wound healing are characterized by the expression of -SMA. 38) Activated HSC is associated with cell proliferation and the accumulation of ECM, including collagen type I and -SMA. The initiation stage is followed by the perpetuation stage, in which increased -SMA and collagen type I are amplified by enhanced growth factor expression, including TGF-1.
39) Alpha-SMA is a definite marker of transdifferentiation of stellate cells. 40) Our experiment shows that CC reduces -SMA and PDGFR-expression in HSC-T6 cells. The results strongly indicate that CC alleviates hepatic fibrosis by blocking PDGFR-and TGF-1 signals. It has also been found that CC regulates -SMA expression by various means, including inhibition of HSC activation. In other words, CC might regulate liver fibrosis by inhibiting HSC activation.
Chronic liver disease develops via excessive accumulation of extracellular matrix proteins, including collagen. 41) Generally, a normal liver can be sustained by ECM homeostasis. During liver fibrosis and cirrhosis, excessive synthesis of ECM proteins deteriorates the hepatic architecture. 42, 43) As a result, homeostasis of ECM is broken and TIMP-1 expression is increased. 44) Homeostasis of ECM is maintained by the action of a specific system of proteolytic enzymes known as matrix metalloproteinase (MMP) and TIMP. 44) TIMP-1 plays an important role in the progression of liver fibrosis. 40, 45) TIMP-1 expression is induced by a variety of stimuli, including PMA, TGF-, serum, retinoids, and interleukin-6/oncostatin M. 46) On TIMP-1 Western blotting assay, CCE reduced the protein level of PMA-induced TIMP-1 expression in the HSC-T6 cells. This means that CCE can help in the homeostasis of ECM, as well as inhibit HSC activation, preventing liver fibrogenesis.
High-dose DMN treatment caused acute liver injury, leading to shrunken livers, accumulation of hydroxyproline, and biological changes. 47) Recently, high-dose DMN-induced liver injury in rats is used as a research model for acute liver injury and the early stage of liver fibrosis. 47) Hence this study investigated the effects of CC on acute liver injury using the DMN-induced liver injury model. Clinically, if hepatic disease is in doubt, LFTs (liver function tests) can be done. Because GOT and GPT are enzymatic indicators of tissue damage by toxicants or disease conditions, abnormal levels of GOT and GPT in the plasma are important to clinical pathology and toxicology. 48) In all the control groups at 4 after high-dose DMN treatment, the levels of GOT, GPT, ALP, and other protein markers in the serum were significantly elevated or lowered and the liver was shrunken, while hydroxyproline accumulated in the liver. These results correspond to those of previous studies. 47, 49, 50) In the acute liver injury model, CC administration showed restorative effects on serum T-protein, albumin, T-Bili, D-Bili, GOT, GPT, and ALP. In our study, we obtained a significant result that revealed that CC restored LFT in acute liver injury in vivo. This implies that CC can improve the function and condition of a liver with acute toxic injury. Cirrhotic livers revealed strong -SMA positivity in fibrous septae as well as in the perisinusoidal space of intact hepatocytes at the leading edge of fibrosis. 51) Hydroxyprolin and -SMA showed no difference, as compared to the DMN-treated group in vivo. It is assumed that since treatment of rats with high-dose DMN for 4 was used in the acute hepatic injury model, fibrotic change might not occur in the liver and CC might have no room to affect fibrosis. We assume that our experimental animal model was an acute hepatic injury model due to the use of high-dose DMN for 4, so the fibrotic change in the liver was not sufficient and CC did not affect -SMA and hydroxyproline significantly. Therefore, we suggest that the chronic effects of CC against liver injury in vivo ought to be examined further.
